Business

Earth Science Tech, Inc. (ETST) Executes Phase I Acquisition of RxCompoundStore.com, LLC. and Peaks Curative, LLC.

Earth Science Tech, Inc. (ETST) Executes Phase I Acquisition of RxCompoundStore.com, LLC. and Peaks Curative, LLC..

articleEarth Science Tech, Inc.November 4, 20214/company/earth-science-tech-inc/news/earth-science-tech-inc-etst-executes-phase-i-acquisition-of-rxcompoundstorecom-llc-and-peaks-curative-llc
Earth Science Tech, Inc. (ETST) Executes Phase I Acquisition of RxCompoundStore.com, LLC. and Peaks Curative, LLC.

About this update from Earth Science Tech, Inc.

[{"type":"text","content":"\n DORAL, FL, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused in nutraceutical and pharmaceutical fields, and medical devices, today announces execution of Phase I acquisition of RxCompoundstore.com, LLC. (“RxCS”) and Peaks Curative, LLC. (“PC”) as part of the Company’s new direction and announced dual phase transaction. As of November 3, 2021 RxCS and PC have become a wholly owned subsidiaries under ETST. The transaction includes RxCS’ current operating facility, pharmacist Dr. Eduardo Hernandez, a pharmacist technician, and its owner who purchased RxCS with his two partners during the year 2020. Since the purchase, the partners have been rebranding and expanding RxCS. The owner, Mario Tabraue will be President of both RxCS and PC, and a member of the Company’s board of directors. The marquee expansion of RxCS is PC, slated to launch its website mid-November and its product line during the month of December 2021. PC follows the same marketing structure as successful Hims Health and Blue Chew, offering Tadalafil in both gummy and tablet forms with plans to soon offer additional compounded prescription products as well as over the counter products. Now acquired the Company is currently communicating with key individuals to assist on further expansion of RxCS books/accounts and transition to a larger location to build out a sterile clean room to compound injectables. This expansion will greatly increase compound formulas leading to greater revenue. The Company is also in talks with major celebrities and influencers to endorse and assist in PC’s branding exposure to maximize subscription orders once launched. Phase II’s acquisition of JCR, owned by Mario Tabraue’s former partners in RxCS is slated to execute during the year 2022 once the Company has fully positioned and expanded Phase I acquisitions. At that time, its owners will be joining the board of directors and the founder as ETST’s COO. Once both phases have been complete, the Company will effect a name and stock ticker symbol change to reflect the change in business focus and more accurately represent the collective businesses of the combined companies. About Earth Science Tech, Inc. (ETST)Eart...

More updates from Earth Science Tech, Inc.